SHREE GANESH REMEDIES LTD Intrinsic Value
SGRL · Healthcare · Current price ₹709.9
Is SHREE GANESH REMEDIES LTD undervalued?
DocStoX estimates the fair value of SHREE GANESH REMEDIES LTD at ₹254 per share, versus the current market price of ₹710. That puts the stock about -64.2% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹126), Relative P/E (₹541), Graham floor (₹199). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹126 (bear) to ₹254 (base) to ₹541 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹710 versus an intrinsic value of ₹254, SHREE GANESH REMEDIES LTD currently offers -64.2% of negative margin (i.e. a premium).
More on SHREE GANESH REMEDIES LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.